Patent Challenges in the Pharma Industry
It was great to share pharmaceutical patenting insights with the panel and our audience at the “Patent Challenges in the Pharma Industry”...
Contributors
-
Trade Mark Attorney -
Trainee Trade Mark Attorney -
Partner -
Partner -
-
Senior Associate -
Senior Associate -
Senior Associate -
Trade Mark Assistant -
Associate Patent Attorney -
Trade Mark Assistant -
Technical Assistant -
Marketing and Communications Manager -
Trade Mark Assistant -
Partner -
Associate
Dehns Insights Archive
- November 2019 (4)
- October 2019 (1)
- August 2019 (1)
- July 2019 (2)
- June 2019 (2)
- April 2019 (4)
- March 2019 (2)
- February 2019 (3)
- January 2019 (6)
- December 2018 (2)
- November 2018 (8)
- October 2018 (3)
- September 2018 (7)
- August 2018 (3)
- July 2018 (3)
- June 2018 (6)
- May 2018 (7)
- April 2018 (14)
- March 2018 (12)
- February 2018 (8)
- January 2018 (8)
- December 2017 (8)
- November 2017 (3)
- October 2017 (12)
- September 2017 (8)
- August 2017 (6)
- July 2017 (5)
- June 2017 (7)
- May 2017 (5)
- April 2017 (3)
- March 2017 (5)
- February 2017 (5)
- January 2017 (3)
- December 2016 (1)
- November 2016 (7)
- October 2016 (7)
- September 2016 (12)
- August 2016 (9)
- July 2016 (6)
- June 2016 (13)
- May 2016 (34)
Is this the end of SPC protection for second medical indications in Europe?
IP practice around Europe is at its most inconsistent when it comes to Supplementary Protection Certificate (SPC) protection for second...
Is a higher purity of a known material patentable?
In what may come as a welcome departure from existing practice, an EPO board of appeal in decision T1085/13 has clarified the conditions...
Patent Challenges in the Pharma Industry - Innovation & IP Forum Paris
Looking forward to joining my fellow panelists for the “Patent Challenges in the Pharma Industry” session at the Innovation & IP...
Brexit Update - Trade Marks and Designs
Following the UK Parliament’s recent rejection of the Prime Minister’s draft Withdrawal Agreement, the uncertainty over Brexit continues....
It’s a McLoss for McDonald’s
In a decision that may come as somewhat of a surprise to lovers of McDonald’s Big Mac sandwich, the EUIPO cancellation division has...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
-
Search site
-
Contact our offices